Impact of insulin resistance, obesity and the metabolic syndrome on time taken to examine the small bowel at capsule endoscopy

Not Applicable

Completed

• Conditions: Diabetes; Insulin resistance; Metabolic syndrome; Obscure gastrointestinal bleeding; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Diet and Nutrition - Obesity; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12621001593820
• Lead Sponsor: Dr Milan Bassan

Brief Summary

Increasing blood glucose levels are associated with reduced transit time through the small intestine. Increased gastric transit time is associated with increased small intestinal transit time.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2010-09-30
• Study Start: 2021-11-22
• Last Update Posted: 24 January 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

All patients being referred for capsule endoscopy

Exclusion Criteria

Unable to provide informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Small intestinal transit time which is measured routinely by the clinician reading the study. The value is accessed from the capsule endoscopy report.[At time of capsule endoscopy]

Secondary Outcome Measures

Name	Time	Method
Gastric transit time which is measured routinely by the clinician reading the study. The value is accessed from the capsule endoscopy report.[At time of capsule endoscopy];Complete enteroscopy which is measured routinely by the clinician reading the study. The value is accessed from the capsule endoscopy report.[At time of capsule endoscopy]